Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?
Journal of Enterocolitis · 2024
DOI: 10.14744/jenterocolitis.2024.240566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Enterocolitis, 2024. Verfasst von Sezen Genç Uluçeçen.
Abstract (Originalsprache)
Ulcerative colitis is a chronic disease that originates in the rectum and progressively involves other areas, leading to episodes of bloody stools and diarrhea.The primary treatment for ulcerative colitis is mesalamine, known for its excellent safety profile.Additionally, other therapeutic options include thiopurines, tumor necrosis factor alpha (TNF) antagonists, anti-integrin agents, and monoclonal antibodies targeting IL 12 and 23. 1 Steroids are also employed, primarily for inducing remission rather than maintaining it.Despite the availability of these treatments, some patients do not achieve remission.In such cases, colectomy is considered.The JAK family activates the STAT pathway through autophosphorylation, regulating numerous immune mediators, including Type 1 Interferon (IFN), IFN-γ, and interleukins 2, 4, 6, 7, 9, 12, 15, 21, and 23.2,3 Tofacitinib, an oral medication that inhibits all JAKs, primarily targets JAK 1 and 3. 4 Our study focused on assessing the effectiveness of tofacitinib induction therapy as a salvage treatment in patients with severe active ulcerative colitis, particularly those who have previously been treated with more than one biological agent.We present the efficacy of tofacitinib in a small case series.
Zitieren
APA
Uluçeçen, S. G. (2024). Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?. Journal of Enterocolitis. https://doi.org/10.14744/jenterocolitis.2024.240566
Vancouver
Uluçeçen SG. Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?. Journal of Enterocolitis. 2024. doi:10.14744/jenterocolitis.2024.240566
BibTeX
@article{Ulueen2024,
author = {Uluçeçen, Sezen Genç},
title = {Is Tofacitinib an Option for Salvage Therapy in Active Acute Severe Ulcerative Colitis?},
journal = {Journal of Enterocolitis},
year = {2024},
doi = {10.14744/jenterocolitis.2024.240566}
}
EUVIMED